Progress toward prevention and control of hepatitis C virus infection - Egypt, 2001-2012

Morbidity and Mortality Weekly Report

Volumn 61, Issue 29, 2012, Pages 545-549

  El Sayed, Nasr ^a   Kandeel, Amr ^a   Genedy, Mohamed ^a   Esmat, Gamal ^b   Doss, Wahid ^b   El Sayed, Manal ^b   Al Gasseer, Naeema ^c   Eltantawy, Nasr ^c   El Bushra, Hassan ^c   Talaat, Maha ^d   Harmanci, Hande ^c   Fontanet, Arnaud ^e   Bernier, Adeline ^e   Tohme, Rania A ^f   Averhoff, Francisco ^f  

^a Ministry of Health and Population   (United States)

^b National Committee for the Control of Viral Hepatitis   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d US Naval Medical Research Unit No 3 Egypt   (Egypt)

^e INSTITUT PASTEUR   (France)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; EGYPT; HEALTH CARE FACILITY; HEALTH SURVEY; HEPATITIS C; HUMAN; IATROGENIC DISEASE; INCIDENCE; INFECTION CONTROL; METHODOLOGY; PREVALENCE; PUBLIC HEALTH; RENAL REPLACEMENT THERAPY;

EGYPT; HEALTH FACILITIES; HEPATITIS C; HUMANS; IATROGENIC DISEASE; INCIDENCE; INFECTION CONTROL; NATIONAL HEALTH PROGRAMS; POPULATION SURVEILLANCE; PREVALENCE; RENAL DIALYSIS;

EID: 84865037170     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. The Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004;44:20-9.
2. El-Zanaty F, Way A. Egypt demographic and health survey 2008. Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International; 2009. Available at http://www.measuredhs.com/pubs/pdf/fr220/fr220.pdf. Accessed July 18, 2012.
3. Paez Jimenez A, Mohamed MK, Sharaf Eldin N, et al. Injection drug use is a risk factor for HCV infection in urban Egypt. PloS One 2009; 4:e7193.
4. Paez Jimenez A, Sharaf Eldin N, Rimlinger F, et al. HCV iatrogenic and intrafamilial transmission in greater Cairo, Egypt. Gut 2010; 59:1554-60.
5. Strickland G. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 2006;43:915-22.
6. Mostafa A, Taylor S, El-Daly M, et al. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver Int 2010;31:560-6.
7. Talaat M, El-Oun S, Kandeel A, et al. Overview of injection practices in two governorates in Egypt. Trop Med Int Health 2003;8:234-41.
8. Talaat M, Kandeel A, Rasslan O, et al. Evolution of infection control in Egypt: achievements and challenges. Am J Infect Control 2006; 34:193-200.
9. Ford N, Singh K, Cooke GS, et al. Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS. Clin Infect Dis 2012;54:1465-72.
10. Deuffic-Burban S, Mohamed M, Larouze B, Carrat F, Valleron A. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol 2006;44:455-61.